| Thromboembolism |
0 |
1 |
| Atrial Fibrillation |
0 |
0.83 |
| Clinical Guidelines |
0 |
0.66 |
| Revenue and Practice Management |
0 |
0.5 |
| Anticoagulation Therapy |
0 |
0.46 |
| Cerebrovascular Accident |
0 |
0.42 |
| Pulmonary Embolism |
0 |
0.38 |
| Insurance |
0 |
0.34 |
| Embolism |
0 |
0.23 |
| Food and Drug Administration (FDA) |
0 |
0.23 |
| Medicaid |
0 |
0.23 |
| Medicare |
0 |
0.23 |
| Deep Venous Thrombosis |
0 |
0.19 |
| Blood |
0 |
0.12 |
| Clinical Research |
0 |
0.12 |
| Crime |
0 |
0.12 |
| Dorsum |
0 |
0.12 |
| Generics |
0 |
0.12 |
| Heart |
0 |
0.12 |
| Hematology |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Kentucky |
0 |
0.12 |
| Medical Literature |
0 |
0.12 |
| Patient History |
0 |
0.12 |
| Professional Development |
0 |
0.12 |
| Thrombosis |
0 |
0.12 |
| Vein |
0 |
0.12 |
| Venous Thromboembolism (VTE) |
0 |
0.12 |